Physician profile
Steven Thorne
NPI 1871561431
$13,761.84
in general payments reported to CMS, 2019-2025
32 companies · $604 in 2025
The $604 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $806 · 2021: $3,550 · 2022: $4,902 · 2023: $1,436 · 2024: $1,334 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,374.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $3,732.00 | 2021-2024 | Treo Abdominal Stent-Graft System |
| Medtronic, INC. | $3,518.76 | 2021-2025 | Endurant Iis, Nim Vital |
| W. L. Gore & Associates, INC. | $1,559.45 | 2019-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Silk Road Medical, INC. | $1,014.31 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $629.10 | 2019-2022 | |
| Medtronic Vascular, INC. | $537.33 | 2020 | |
| Shockwave Medical, INC | $516.86 | 2021-2022 | |
| Ethicon US, LLC | $335.38 | 2019-2022 | |
| Boston Scientific Corporation | $269.31 | 2020-2025 | Enroute Transcarotid Neuroprotection System |
| Penumbra, INC. | $268.35 | 2021-2025 | Penumbra System |
| Smith+Nephew, INC. | $209.53 | 2019-2023 | Oasis, Grafix, Grafix Pl |
| Lemaitre Vascular, INC. | $192.40 | 2019-2025 | Artegraft Vascular Graft, Flexcel Carotid Shunt |
| Intuitive Surgical, INC. | $130.48 | 2019-2024 | |
| Elutia, INC. | $124.36 | 2022 | |
| Osiris Therapeutics INC. | $98.09 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $89.20 | 2022 | |
| Veryan Medical Incorporated | $86.76 | 2021 | |
| Abbvie INC. | $60.30 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Kowa Pharmaceuticals America, INC. | $51.82 | 2022-2023 | Seglentis |
| Endogastric Solutions, INC | $43.66 | 2022 | |
| Janssen Pharmaceuticals, INC | $37.67 | 2019 | |
| Teleflex LLC | $37.11 | 2025 | Deknatel |
| Kerecis Limited | $31.83 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Innocoll Pharmaceuticals Limited | $29.97 | 2021 | |
| Cordis US Corp. | $28.30 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.31 | 2024 | Exparel |
| Acera Surgical, INC. | $21.25 | 2020 | |
| Getinge USA Sales, LLC | $19.93 | 2021 | |
| Bolder Surgical LLC | $18.99 | 2019 | |
| Hologic Sales and Service, LLC | $17.60 | 2024 | Localizer |
| Allergan, INC. | $14.61 | 2020 | |
| Ferring Pharmaceuticals INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Thorne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.